|
1
|
Baldwin LA, Huang B, Miller RW, Tucker T,
Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR
and Seamon LG: Ten-year relative survival for epithelial ovarian
cancer. Obstet Gynecol. 120:612–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bae T, Weon KY, Lee JW, Eum KH, Kim S and
Choi JW: Restoration of paclitaxel resistance by CDK1 intervention
in drug-resistant ovarian cancer. Carcinogenesis. 36:1561–1571.
2015.PubMed/NCBI
|
|
3
|
Yoo YD and Kwon YT: Molecular mechanisms
controlling asymmetric and symmetric self-renewal of cancer stem
cells. J Anal Sci Technol. 6:282015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beachy PA, Karhadkar SS and Berman DM:
Tissue repair and stem cell renewal in carcinogenesis. Nature.
432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levina V, Marrangoni AM, DeMarco R,
Gorelik E and Lokshin AE: Drug-selected human lung cancer stem
cells: Cytokine network, tumorigenic and metastatic properties.
PLoS One. 3:e30772008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klonisch T, Wiechec E, Hombach-Klonisch S,
Ande SR, Wesselborg S, Schulze-Osthoff K and Los M: Cancer stem
cell markers in common cancers - therapeutic implications. Trends
Mol Med. 14:450–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li F, Tiede B, Massagué J and Kang Y:
Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res.
17:3–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vezzoni L and Parmiani G: Limitations of
the cancer stem cell theory. Cytotechnology. 58:3–9. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sahai E and Marshall CJ: RHO-GTPases and
cancer. Nat Rev Cancer. 2:133–142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hakem A, Sanchez-Sweatman O, You-Ten A,
Duncan G, Wakeham A, Khokha R and Mak TW: RhoC is dispensable for
embryogenesis and tumor initiation but essential for metastasis.
Genes Dev. 19:1974–1979. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kleer CG, Teknos TN, Islam M, Marcus B,
Lee JS, Pan Q, Merajver SD and Rho C: RhoC GTPase expression as a
potential marker of lymph node metastasis in squamous cell
carcinomas of the head and neck. Clin Cancer Res. 12:4485–4490.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Islam M, Sharma S and Teknos TN: RhoC
regulates cancer stem cells in head and neck squamous cell
carcinoma by overexpressing IL-6 and phosphorylation of STAT3. PLoS
One. 9:e885272014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosenthal DT, Zhang J, Bao L, Zhu L, Wu Z,
Toy K, Kleer CG and Merajver SD: RhoC impacts the metastatic
potential and abundance of breast cancer stem cells. PLoS One.
7:e409792012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Chen X, Xiu YL, Sun KX and Zhao Y
and Zhao Y: Inhibition of ovarian epithelial carcinoma
tumorigenesis and progression by microRNA 106b mediated through the
RhoC pathway. PLoS One. 10:e01257142015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Chen S, Xiu YL, Sun KX, Zong ZH
and Zhao Y: RhoC is a major target of microRNA-93-5P in epithelial
ovarian carcinoma tumorigenesis and progression. Mol Cancer.
14:312015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen S, Wang J, Gou WF, Xiu YL, Zheng HC,
Zong ZH, Takano Y and Zhao Y: The involvement of RhoA and Wnt-5a in
the tumorigenesis and progression of ovarian epithelial carcinoma.
Int J Mol Sci. 14:24187–24199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lukenda A, Dotlic S, Vukojevic N, Saric B,
Vranic S and Zarkovic K: Expression and prognostic value of
putative cancer stem cell markers CD117 and CD15 in choroidal and
ciliary body melanoma. J Clin Pathol. 69:234–239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wright MH, Calcagno AM, Salcido CD,
Carlson MD, Ambudkar SV and Varticovski L: Brca1 breast tumors
contain distinct CD44+/CD24 and CD133+ cells
with cancer stem cell characteristics. Breast Cancer Res.
10:R102008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie SL, Zhu MG, Chen GF, Wang GY and Lv
GY: Effects of Ras homolog gene family, member C gene silencing
combined with rapamycin on hepatocellular carcinoma cell growth.
Mol Med Rep. 12:5077–5085. 2015.PubMed/NCBI
|
|
21
|
Mitin N, Rossman KL, Currin R, Anne S,
Marshall TW, Bear JE, Bautch VL and Der CJ: The RhoGEF TEM4
regulates endothelial cell migration by suppressing actomyosin
contractility. PLoS One. 8:e662602013. View Article : Google Scholar : PubMed/NCBI
|
